Company / Current Liabilities
Thermo Fisher Scientific Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$15.2B
FY2025
5-year range
$13.3B / $17.0B
FY2021-FY2025
Trend
+13.9%
vs FY2024
Sector context
#12 of 160
Health Care
What the data says
Among 160 Health Care companies, Thermo Fisher Scientific is in the bottom 7% for current liabilities. Current Liabilities returned to growth in FY2025 after 2 years of decline, reaching $15.2B.
Based on SEC 10-K filings.
$15.2B in FY2025 with a 5-year CAGR of +8.1%. Top quartile in the Health Care sector.
Increased from $14.0B to $15.2B over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -3.7%
- 5-Year CAGR
- +8.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 160This company $15.2B Sector average $4.5B
▼
+239.1% above sector average
Key checks
Key Insights
- 5-year CAGR of +8.1%, indicating consistent growth.
- In FY2025, current liabilities increased 13.9% year-over-year.
- Ranks #12 out of 160 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2022.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.2B | +13.9% |
| FY2024 | $13.3B | -4.9% |
| FY2023 | $14.0B | -17.6% |
| FY2022 | $17.0B | +26.6% |
| FY2021 | $13.4B | +30.4% |
| FY2020 | $10.3B | +66.3% |
| FY2019 | $6.2B | +0.8% |
| FY2018 | $6.1B | -12.8% |
| FY2017 | $7.0B | +44.8% |
| FY2016 | $4.9B | +17.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026